✦ LIBER ✦

The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection

✍ Scribed by Kenji Maeda; Hirotomo Nakata; Hiromi Ogata; Yasuhiro Koh; Toshikazu Miyakawa; Hiroaki Mitsuya

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HIV-1 Protease Inhibitors: Development,

✍ Marc Lang; Johannes Roesel 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 1 views

Mutational analysis of the CCR5 and CXCR

✍ V. Alvarez; Carlos López-Larrea; Eliecer Coto 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 91 KB

[Methods and Principles in Medicinal Che

✍ Ghosh, Arun K. 📂 Article 📅 2011 🏛 Wiley-VCH Verlag GmbH & Co. KGaA ⚖ 302 KB

Current Status of the Research and Devel

✍ DeVita, Robert J.; Pinto, Shirly 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 309 KB

Therapeutic advances: protease inhibitor

✍ J. Misson; W. Clark; M. J. Kendall 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 745 KB

Prevalence of the CCR5Δ32 mutation in Br

✍ Rogério Grimaldi; Nice Shindo; Angelina Acosta; Inês Dourado; Carlos Brites; Oze 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 41 KB